| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/09/1997 | WO1997016461A1 Monoclonal antibody specific for prostaglandin d synthetase |
| 05/09/1997 | WO1997016459A1 Use of protein gax for treating cancer |
| 05/09/1997 | WO1997016458A1 Apolipoprotein e2 and treatment of alzheimer's disease |
| 05/09/1997 | WO1997016457A2 Anti-tumoral protein |
| 05/09/1997 | WO1997016439A1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 05/09/1997 | WO1997016221A2 Genetic induction of receptors for targeted radiotherapy |
| 05/09/1997 | WO1997016209A1 Expression of cyclin g1 in tumors |
| 05/09/1997 | WO1997016207A1 Peptide expression and delivery system |
| 05/09/1997 | WO1997016206A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |
| 05/09/1997 | WO1997016171A1 Membrane-fusible liposome with the use of recombinant sendai virus |
| 05/09/1997 | WO1997016064A1 Methods and compositions for the reduction of xenotransplantation rejection |
| 05/09/1997 | WO1997012039A3 Sh2-containing inositol-phosphatase |
| 05/09/1997 | WO1997011196A3 Detection of nucleic acids in cells by thermophilic strand displacement amplification |
| 05/09/1997 | WO1997011179A3 VARIANTS OF HUMAN RECOMBINANT INTERFERON-η (RHU-IFN-η) HAVING INCREASED HEAT-STABILITY |
| 05/09/1997 | WO1997011173A3 Nucleic acid molecule encoding tgf receptor having modified growth inhibition, and its use |
| 05/09/1997 | WO1997004104A3 Tumor type ii hexokinase transcription regulatory regions |
| 05/09/1997 | WO1997004089A3 Porphyrin-accumulating type herbicide resistance gene |
| 05/09/1997 | WO1997003186A3 Method for in vitro proliferation of dentritic cells, composition containing the cells entrapped in a three-dimensional matrix and use for immunization |
| 05/09/1997 | WO1996034885A3 Biologically active peptide fragments of ob protein |
| 05/09/1997 | CA2236675A1 Double-stranded conformational polymorphism analysis |
| 05/09/1997 | CA2236448A1 Molecular cloning by multimerization of plasmids |
| 05/09/1997 | CA2236419A1 Neurogenic differentiation (neurod) genes and proteins |
| 05/09/1997 | CA2236381A1 Mutant mono-oxygenase cytochrome p450cam |
| 05/09/1997 | CA2236297A1 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 05/09/1997 | CA2236274A1 Apolipoprotein e2 and treatment of alzheimer's disease |
| 05/09/1997 | CA2235748A1 Plants with reduced glucosinolate content |
| 05/09/1997 | CA2235623A1 Dna sequences encoding cmh-1, a cysteine protease involved in apoptosis |
| 05/09/1997 | CA2235619A1 Modified plants and plant products |
| 05/09/1997 | CA2235223A1 Rationally designed polysaccharide lyases derived from heparinase i |
| 05/09/1997 | CA2234667A1 Human hepatitis b virus dna |
| 05/09/1997 | CA2234102A1 Genetic induction of receptors for targeted radiotherapy |
| 05/09/1997 | CA2233881A1 Chitin synthase 1 |
| 05/09/1997 | CA2233250A1 Use of protein gax for treating cancer |
| 05/09/1997 | CA2209314A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |
| 05/09/1997 | CA2208871A1 New e.coli mutant with suppressed organic acid production |
| 05/09/1997 | CA2189381A1 Entrapment of nucleic acid sequencing template in sample mixtures by entangled polymer networks |
| 05/08/1997 | CA2189499A1 Immortalised embryonic hippocampal cells and their use |
| 05/07/1997 | EP0771879A1 $g(a)-KETOGLUTARIC DEHYDROGENASE GENE |
| 05/07/1997 | EP0771878A1 Plants with reduced glucosinolate content |
| 05/07/1997 | EP0771877A1 Gene coding for modified bone morphogenic protein receptor |
| 05/07/1997 | EP0771876A1 PROCESS FOR PRODUCING cis-3-HYDROXY-L-PROLINE |
| 05/07/1997 | EP0771875A1 Porcine CNP gene and precursor protein |
| 05/07/1997 | EP0771874A2 Transgenic protein production |
| 05/07/1997 | EP0771873A2 Neuronal cell-specific receptor protein |
| 05/07/1997 | EP0771872A1 Process of polymerization of nucleic acid sequences and their applications |
| 05/07/1997 | EP0771871A2 Expression of human serum albumin in methylotrophic yeasts |
| 05/07/1997 | EP0771870A1 Reversible inactivation of thermostable enzymes by using dicarboxylic acid anhydride and use in amplification methods |
| 05/07/1997 | EP0771362A1 Genetic diagnosis of prostate cancer |
| 05/07/1997 | EP0771361A2 Diagnostic method and probe |
| 05/07/1997 | EP0771360A1 Method for the detection of the antibiotic resistance spectrum of mycobacterium species |
| 05/07/1997 | EP0771359A1 Construction of nucleoprotein based assemblies comprising addressable components for nanoscale assembly and nanoprocessors |
| 05/07/1997 | EP0771358A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof |
| 05/07/1997 | EP0771356A1 Methods for the preparation of retroviral particles and cell lines deficient in the alpha-galactosyl epitope |
| 05/07/1997 | EP0771355A1 A method for large scale plasmid purification |
| 05/07/1997 | EP0771354A1 Thermophilic fungal expression system |
| 05/07/1997 | EP0771353A1 Dna, constructs, cells and plants derived therefrom |
| 05/07/1997 | EP0771352A1 Lkp pilin structural genes and operon of nontypable haemophilus influenzae |
| 05/07/1997 | EP0771351A1 Surface protein of staphylococcus aureus |
| 05/07/1997 | EP0771350A1 Growth control for cells encapsulated within bioartificial organs |
| 05/07/1997 | EP0771348A1 Bradykinin b2 receptor modified transgenic non-human animals |
| 05/07/1997 | EP0771327A1 Contraceptive vaccine |
| 05/07/1997 | EP0771325A1 Process for modifying the stability of antibodies |
| 05/07/1997 | EP0771320A1 Polynucleotide decoys that ihnibit mhc-ii expression and uses thereof |
| 05/07/1997 | EP0771216A1 Methods and compositions for the specific coagulation of vasculature |
| 05/07/1997 | EP0771215A1 Retroviral transduction of cells using soluble complement inhibitors |
| 05/07/1997 | EP0771213A1 Haemophilus adherence and penetration proteins |
| 05/07/1997 | EP0771212A1 Contraceptive vaccine |
| 05/07/1997 | EP0771210A1 TWO NON-CONTIGUOUS REGIONS CONTRIBUTE TO NIDOGEN BINDING TO A SINGLE EGF-LIKE MOTIF OF THE LAMININ $g(g)1 CHAIN |
| 05/07/1997 | EP0771208A1 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 05/07/1997 | EP0771147A1 Compositions and methods for enhanced tumor cell immunity in vivo |
| 05/07/1997 | EP0686202A4 Prenatal screening |
| 05/07/1997 | EP0684999A4 Sequence-directed dna-binding molecules compositions and methods. |
| 05/07/1997 | EP0670907B1 Preventing endogenous aminopeptidase mediated n-terminal amino acid cleavage during expression of foreign genes in bacteria |
| 05/07/1997 | EP0668917B1 Riboflavin synthesis in yeast |
| 05/07/1997 | EP0666927B1 Method of detecting a nucleic acid sequence |
| 05/07/1997 | EP0661993B1 Protection against liver damage by hgf |
| 05/07/1997 | EP0656747A4 Composition and method for altering dna sequences by homologous recombination. |
| 05/07/1997 | EP0655090A4 Detection of gene sequences in biological fluids. |
| 05/07/1997 | EP0652957B1 Assembled viral particles and their use in a vaccine to rotaviral disease |
| 05/07/1997 | EP0621870B1 A human kunitz-type protease inhibitor variant |
| 05/07/1997 | EP0620858A4 Site-directed mutagenesis of dna. |
| 05/07/1997 | EP0612217B1 Bacillus thuringiensis isolates active against cockroaches and genes encoding cockroach-active toxins |
| 05/07/1997 | EP0566571B1 Diagnosis of metastatic cancer by the mts-1 gene |
| 05/07/1997 | EP0515554B1 Method for generating and screening useful peptides |
| 05/07/1997 | EP0476093B1 Production of improved rapeseed exhibiting a reduced saturated fatty acid content |
| 05/07/1997 | EP0357645B1 Improved process for recovering microbially produced interleukin-2 |
| 05/07/1997 | DE19540902A1 Protein mit Anti-Tumorwirkung Protein with anti-tumor activity |
| 05/07/1997 | CN1149319A Angiostatin and method of use for inhibition of Angiogenesis |
| 05/07/1997 | CN1149318A Luciferases |
| 05/07/1997 | CN1149317A DNA sequences |
| 05/07/1997 | CN1149299A Anti-GP39 antibodies and uses therefor |
| 05/07/1997 | CN1149258A Inhibin compositions and methods of use thereof |
| 05/07/1997 | CN1148984A Process for preparing pharmaceutical formulation containing insulin analog |
| 05/06/1997 | US5627277 Method for analyzing oligonucleotide analogs |
| 05/06/1997 | US5627274 Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
| 05/06/1997 | US5627270 Glycosylated steroid derivatives for transport across biological membranes and process for making and using same |
| 05/06/1997 | US5627268 Hemoglobin comprising globin fusion proteins |
| 05/06/1997 | US5627267 Cytokine designated elk ligand |
| 05/06/1997 | US5627265 Receptor for cell-binding domain of thrombospondins |
| 05/06/1997 | US5627264 Chimeric complement inhibitor proteins |